Narrative review of migraine management in patients with renal or hepatic disease.

Source: Headache 2023 Jan; 63(1). doi: 10.1111/head.14437Authors: Stern JI, Datta S, Chiang C-C, Garza I, Vieira DL, Robertson CE

Treatment of migraine in the setting of either renal or hepatic disease can be daunting for clinicians. Not only does the method of metabolism have to be considered, but also the method of elimination/excretion of the parent drug and any active or toxic metabolites. Furthermore, it is difficult to think about liver or kidney disease in isolation, as liver disease can sometimes contribute to impaired renal function and renal disease can sometimes impair hepatic metabolism, through the cytochrome P450 system.

Pubmed ID: http://www.ncbi.nlm.nih.gov/pubmed/36709407?dopt=Abstract